| Jul 30 2024 |
FCA Enforcement & Compliance Digest — Summer 2024 False Claims Act Newsletter |
ArentFox Schiff LLP |
| Jul 30 2024 |
EPA Publishes Compliance Guide for Final Methylene Chloride Risk Management Rule |
Bergeson & Campbell, P.C. |
| Jul 30 2024 |
Safety Basics IV: The General Duty Clause [Podcast] |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Jul 30 2024 |
FAQ: What Medical Practices Need to Know Regarding Communicating with Patients via Telephone and Text |
Ward and Smith, P.A. |
| Jul 30 2024 |
Trending in Telehealth: July 16 – 22, 2024 |
McDermott Will & Schulte LLP |
| Jul 29 2024 |
Advancements in CAR-T Therapy Manufacturing Processes |
Foley & Lardner LLP |
| Jul 29 2024 |
CMS Changes Agent Requirements to Address Unauthorized Consumer Marketplace Enrollments |
Polsinelli PC |
| Jul 29 2024 |
Pennsylvania Latest to Curtail Use of Non-Competes |
Polsinelli PC |
| Jul 29 2024 |
Challenges to LDT Final Rule Continue as Rule Goes into Effect |
Polsinelli PC |
| Jul 29 2024 |
FDA Issues Guidance Intended to Diversify and Enhance Clinical Trial Participation |
Mintz |
| Jul 29 2024 |
HHS-OIG Highlights Anti-Fraud Safeguards Of Refund, Discount Program Offered By Pharma To Alleviate Drug's Cost |
Barnes & Thornburg LLP |
| Jul 29 2024 |
Healthcare Preview for the Week of: July 29, 2024 [Podcast] |
McDermott Will & Schulte LLP |
| Jul 29 2024 |
Post-Chevron Health Care Regulations: Using Loper Bright as a Shield in Stark Law Litigation |
ArentFox Schiff LLP |
| Jul 29 2024 |
Post-Chevron Employment Law Regulations: What to Expect |
ArentFox Schiff LLP |
| Jul 29 2024 |
Substance Use Disorder Treatment Services: 2025 Physician Fee Schedule Proposed Rule Would Expand Access and Medicare Coverage |
Foley & Lardner LLP |
| Jul 29 2024 |
WHO PFAS Drinking Water Recommendations Reverse Course |
CMBG3 Law |
| Jul 27 2024 |
Louisiana Limits Non-Compete Agreements for Physicians |
Jackson Lewis P.C. |
| Jul 26 2024 |
M+ Check-Up: July 26, 2024 |
McDermott Will & Schulte LLP |
| Jul 26 2024 |
PFAS Health Advisory Challenge Struck Down By Court |
CMBG3 Law |
| Jul 26 2024 |
Federal Court Dismisses $680 Million FCA Suit |
ArentFox Schiff LLP |
| Jul 26 2024 |
This Week in 340B: July 16 – 22, 2024 |
McDermott Will & Schulte LLP |
| Jul 26 2024 |
New Proposed Federal Legislation Takes Aim at Concerns Regarding Perceived “Looting” of Health Care Systems by Private Equity Investors |
Epstein Becker & Green, P.C. |
| Jul 26 2024 |
Unraveling Fraud Like a Double Helix: Two Whistleblowers Receive Over $860,000 for Reporting Genetic Testing Kickbacks |
Tycko & Zavareei LLP |
| Jul 25 2024 |
Understanding MSHA’s Impact Inspections |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Jul 25 2024 |
More on Braidwood: ACA Preventive Services Mandate Remains Mostly in Place (For the Time Being) |
Proskauer Rose LLP |
| Jul 25 2024 |
Should the DEA Allow Providers to Prescribe Controlled Substances via Telehealth Means? |
Bradley Arant Boult Cummings LLP |
| Jul 25 2024 |
Washington Shake-Up: Vice President Harris to Lead Democratic Nomination for 2024 Presidency |
Mintz |
| Jul 25 2024 |
How Does the End of Chevron Deference Change the Relationship Between the Health Care Industry, Federal Regulators, and Congress? |
Epstein Becker & Green, P.C. |
| Jul 25 2024 |
California’s New Heat Illness Prevention Standard for Indoor Workplaces Is Now Effective |
Sheppard, Mullin, Richter & Hampton LLP |
| Jul 25 2024 |
Advocate Aurora Health $12.2M Pixel Litigation Settlement Approved by Court |
Robinson & Cole LLP |
| Jul 25 2024 |
Using AI for Worker Safety: Benefits and Risks |
Robinson & Cole LLP |
| Jul 25 2024 |
Massachusetts Senate Passes Bill to Increase Oversight of Private Equity Healthcare Transactions |
Sheppard, Mullin, Richter & Hampton LLP |
| Jul 25 2024 |
SEEING CLEARLY: Court Rejects Application of FCC Healthcare Exemption in Context of Calls to Number on DNC And it Makes Sense |
Troutman Amin, LLP |
| Jul 25 2024 |
Diagnosing Health Care Podcast – Episode 79: The Future of Laboratory Testing Just Got a Little Clearer: FDA's Final Rule on LDTs [Podcast] |
Epstein Becker & Green, P.C. |
| Jul 25 2024 |
Private Equity Firms Should Prepare for Increased Scrutiny as DOJ Puts False Claims Violations Under the Microscope |
K&L Gates LLP |
